Heiko Schuster

This inventor holds 154 USPTO granted patents and 98 published patent applications and 3 EPO patents, primarily in Immunotherapy Peptides (CPC class C07K14-4748). Top assignee: Immatics Biotechnologies Gmbh. Active years: 2018-2026.

USPTO Granted Patents = 154 (Patent Applications = 98)

% Patents Active = 61.0

EPO Patents = 3 (Patent Applications = 22)

Average Co-Inventor Count = 6.6

ph-index = 8

Forward Citations = 146(Granted Patents)

Forward Citations (Not Self Cited) = 30(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Tübingen, DE (2021)
Tuebingen, DE (2018 - 2024)

Company Filing History:

152 out of 728

Immatics Biotechnologies Gmbh

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Antigen Binding Proteins

HLA Displayed Peptides

Cancer Treatments

Immunotherapy

Peptide:MHC Binding

Combination Peptides

B*07 Restricted Peptides

B*44 Restricted Peptides

A*01 Restricted Peptides

Ovarian Cancer

Non-Canonical Peptides

PRAME

154 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570760 - Antigen binding proteins specifically binding PRAME (2026-03-10),

2. 12480958 - METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES (2025-11-25),

3. 12318407 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-06-03),

4. 12290530 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-05-06),

5. 12285443 - Peptides displayed by HLA for use immunotherapy against different types of cancers (2025-04-29),

6. 12274716 - Peptides displayed by HLA for use immunotherapy against different types of cancers (2025-04-14),

7. 12269881 - Antigen binding proteins specifically binding MAGE-A (2025-04-08),

8. 12257269 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-03-25),

9. 12246039 - Peptides displayed by HLA for use in immunotherapy against different types of cancers (2025-03-11),

10. 12227556 - Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods (2025-02-18),

11. 12202878 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods (2025-01-21),

12. 12195516 - Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods (2025-01-14),

13. 12195506 - Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods (2025-01-14),

14. 12162917 - B*44 restricted peptides for use in immunotherapy against cancers and related methods (2024-12-10),

15. 12098183 - Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers (2024-09-24),

Title: Inventor Heiko Schuster - Revolutionizing Technology in Tuebingen

Introduction: Heiko Schuster is a renowned inventor based in Tuebingen, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Heiko Schuster holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Heiko Schuster has worked with leading research institutions and tech companies, spearheading projects that have pushed the boundaries of technological advancements.

Collaborations: Throughout his career, Heiko Schuster has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and knowledge-sharing in the industry.

Conclusion: Heiko Schuster's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists, making him a true pioneer in the world of technology.